Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacologic approaches to smoking cessation.

D P Sachs1, S J Leischow

  • 1Palo Alto Center for Pulmonary Disease Prevention, California.

Clinics in Chest Medicine
|December 1, 1991
PubMed
Summary

Tobacco dependence is a complex neurochemical disorder, not simple overuse. Nicotine itself, delivered via various methods, remains the most effective pharmacologic treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial.

Annals of internal medicine·2001
Same author

Responsiveness of the Smoking Cessation Quality of Life (SCQoL) questionnaire.

Clinical therapeutics·2001
Same author

Cigarette smoking, pulmonary metastases, and breast carcinoma: coincidence or causality?

Chest·2001
Same author

Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2001
Same author

Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo.

Clinical therapeutics·2001
Same author

Bupropion for smoking cessation : predictors of successful outcome.

Chest·2001

Area of Science:

  • Neuroscience
  • Pharmacology
  • Addiction Research

Background:

  • Tobacco dependence was historically viewed as simple overuse.
  • Recent research reveals it as a complex neurochemical and behavioral disorder.
  • Nicotine affects key brain systems: locus coeruleus (arousal, cognition) and mesolimbic system (pleasure).

Purpose of the Study:

  • To review the neurochemical basis of tobacco dependence.
  • To discuss current and emerging pharmacologic treatments.
  • To emphasize the integration of pharmacologic and behavioral therapies.

Main Methods:

  • Literature review of neurochemical and behavioral research on nicotine.
  • Analysis of pharmacologic agents for smoking cessation.
  • Evaluation of treatment efficacy based on scientific evidence.

Main Results:

  • Nicotine acts on specific receptors influencing arousal, cognition, and reward pathways.
  • Nicotine polacrilex is the primary evidence-based pharmacologic treatment.
  • New delivery forms (patch, spray, inhaler) and other agents are under investigation.

Conclusions:

  • Pharmacologic treatments must complement behavioral plans.
  • Nicotine's central nervous system effects are profound.
  • Ongoing research explores novel pharmacological interventions for smoking cessation.

Related Experiment Videos